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Abstract. Low-level laser therapy (LLLT) has been indicated as an adjuvant therapy
for bisphosphonate-induced osteonecrosis. However, the effects of LLLT on
bisphosphonate-treated cells are not yet clear. This study evaluated the effects of
LLLT on the proliferation and apoptosis of gingival fibroblasts treated with
zoledronic acid (ZA). Cells were exposed to ZA at 5 mM for 48 h. Irradiation was
performed using a laser diode prototype (LaserTABLE, InGaAsP; 780 nm  3 nm,
25 mW) at 0.5 or 3 J/cm2, three times every 24 h. Cell proliferation and apoptosis
were evaluated by fluorescence microscopy. Data were analyzed by Mann–Whitney
test at the 5% level of significance. ZA decreased cell proliferation to 47.62%
(interquartile range (IQR) 23.80–57.14%; P = 0.007) and increased apoptosis of
gingival fibroblasts to 27.7% (IQR 20.9–33.4%; P = 0.0001). LLLT increased cell
proliferation compared with non-irradiated cells, at 0.5 J/cm2 (57.14%, IQR 57.14–
71.43%; P = 0.003) and at 3 J/cm2 (76.19%, IQR 61.90–76.19%; P = 0.0001), but
did not increase cell proliferation in ZA-treated cells. Irradiated fibroblasts
presented lower apoptosis rates than the ZA-treated cells, but apoptosis was no
different in ZA-treated cells compared to those that were ZA-treated and also
irradiated.
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The aetiology of osteonecrosis has been
related to the cytotoxic effects of bispho-
sphonates on bone cells,1 a decrease in
local vascularization and oxygen distribu-
tion, as well as the presence of local
infection.2
Bisphosphonates are analogues of pyr-
ophosphate that are prescribed for diseases
associated with intense bone resorption,
such as Paget’s disease, multiple mye-
loma, osteoporosis, bone tumours, and
metastasis.3–5 Bisphosphonate-induced
osteonecrosis has been characterized as
a necrotic bone area in the oral cavity that
persists for longer than 8 weeks without a
history of head and neck radiotherapy.3
Previous studies have shown that
bisphosphonates decrease the prolifera-
tion rate of endothelial cells, interfering
with the tissue repair process.6 Scheper
et al.7 demonstrated that zoledronic acid
(ZA), a high-potency nitrogen-containing
bisphosphonate, inhibits cell proliferation
and induces apoptosis of fibroblasts.
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In addition, Ravosa et al.8 reported a
decrease in motility and synthesis of col-
lagen type I by ZA-treated fibroblasts.
Regarding the controversial aspects of
the treatment of osteonecrosis, topical and
systemic antibiotic therapies, as well as
surgical treatment, have been indicated
widely.9 Recently, low-level laser therapy
(LLLT) has been used clinically as an
adjuvant therapy for this pathological con-
dition, mainly due to its positive effect on
pain relief and tissue repair.9–12
Several researchers have demonstrated
the biostimulatory effects of LLLT on
different cell types, such as increased cell
proliferation, migration, differentiation,
and protein synthesis, as well as gene
expression of collagen type I and growth
factors.13–17 Based on the positive effects
of LLLT on bisphosphonate-induced
osteonecrosis lesions and the toxic effects
of these types of drugs on cells, the aim of
the present study was to evaluate the pro-
liferation and apoptosis rates of gingival
fibroblasts exposed to ZA treatment and
subjected to LLLT according to specific
parameters.
Materials and methods
This research was developed in the univer-
sity laboratory. All experiments were per-
formed using a human gingival fibroblast
continuous cell line (HGF). Cells were
exposed to ZA and irradiated with a laser
diode prototype according to selected para-
meters. The experimental and control
groups are described in Table 1.
Cell culture and zoledronic acid
treatment
Cells were seeded in the wells of 24-well
plates (3  104 cells/cm2) in culture med-
ium (DMEM–Dulbecco’s Modified
Eagle’s Medium; Gibco, Grand Island,
NY, USA), supplemented with 10% foetal
bovine serum (FBS; Gibco), and were
maintained in an incubator at 37 8C and
5% CO2 (Isotemp; Fisher Scientific, Pitts-
burgh, PA, USA).18 After 48 h, the culture
medium was replaced with serum-free
DMEM, which was incubated in contact
with the cells for 24 h. ZA at 5 mM
(8.25 ml/ml) was then added to the
serum-free DMEM and kept in contact
with the cells for an additional 48 h.19
The DMEM with ZA was then replaced
with fresh DMEM, and the cells were
subjected to irradiation by laser diode
prototype. Cells not subjected to laser
irradiation were used as control groups
(G1 and G2). In these groups, the well
plates containing the cells were placed in
the laser diode prototype, which was not
activated.
Low-level laser therapy (LLLT)
Irradiation was performed using a laser
diode prototype (LaserTABLE, InGaAsP;
780 nm  3 nm, 25 mW).16,17,19,20 This
device is composed of 12 laser InGaAsP
(indium–gallium–arsenide–phosphide)
diodes that are positioned to irradiate each
well in a standardized way and individu-
ally. Cells were irradiated three times
every 24 h. The parameters selected for
LLLT were based on the results of pre-
vious studies that have demonstrated
increased cell metabolism and prolifera-
tion, as well as high migration capacity,
after laser irradiation.17 These parameters
are shown in Table 2.
Cell proliferation analysis
(bromodioxyuridine incorporation)
The evaluation of cell proliferation was
performed by the fluorescence method of
bromodioxyuridine (BrdU) incorporation;
BrdU is an analogue of thymidine. This
compound is incorporated into DNA mole-
cules during cell division, demonstrating
the cells in DNA synthesis (proliferation).
A fluorescence kit, Click-iT EdU Imaging
Kit (Invitrogen, Carlsbad, CA, USA), was
used for this evaluation, in accordance with
the manufacturer’s instructions.
Results were analyzed by fluorescence
microscopy (Nikon Eclipse TS 100; Nikon
Corporation, Tokyo, Japan). Fluorescent
nuclei were considered positive. Image
analyzer software (Image J 1.45S soft-
ware; Wayne Rasband, National Institutes
of Health, Bethesda, MD, USA) was used
to determine the numbers of proliferating
cells in four different image fields of each
sample.
Analysis of cell apoptosis – TUNEL assay
Apoptotic cells were evaluated by TUNEL
assay (terminal deoxynucleotidyl transfer-
ase dUTP nick end labelling), which iden-
tifies the DNA fragmentation that is
characteristic of the apoptotic process.20
This assay is based on the action of the
enzyme terminal deoxynucleotidyl trans-
ferase, which adds fluorescent synthetic
nucleotides to the DNA fragments, allow-
ing the identification of DNA ruptures that
are present in apoptotic cells rather than
DNA condensation, observed for cell
death by necrosis.
Permeabilization of the plasma cell
membrane was performed to permit the
influx of fluorescent nucleotides, since this
membrane is intact during the apoptotic
process.20 After that, the TUNEL assay
was performed with a fluorescence kit,
C10245 Click-iT TUNEL (Alexa Fluor
488 Imaging Assay; Invitrogen). A posi-
tive group (treated with DNase) was
included to improve the comparison. Sam-
ples were analyzed by fluorescence micro-
scopy (Nikon Eclipse TS 100; Nikon
Corporation). The positive cells were
counted and analyzed with image software
(Image J 1.45S), and were considered
apoptotic cells.
Statistical analysis
The statistical analyses were performed
using IBM SPSS version 20.0 (IBM Corp.,
Armonk, NY, USA). Data were evaluated
for normal adherence, and as results did
not show normal distribution, the non-
parametric Mann–Whitney test was
selected for the statistical analysis, using
adjusted P-values, considering a 5% sig-
nificance level.
Results
For ZA-treated cells, we observed a sig-
nificant decrease in cell proliferation com-
pared with the control group (P < 0.05).
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Table 1. Experimental groups.
Group Zoledronic acid Energy dose of LLLT (J/cm2)
G1 (control group) No –
G2 Yes –
G3 No 0.5
G4 Yes 0.5
G5 No 3.0
G6 Yes 3.0
LLLT, low-level laser therapy.
Table 2. LLLT irradiation parameters
selected for the experiments.
Parameter
Potency (W) 0.025
Wave length (nm) 780
Energy doses (J/cm2) 0.5; 3.0
Irradiation area (cm2) 2.0
Time (s) 40; 240
LLLT, low-level laser therapy.
The ZA-treated gingival fibroblasts that
were subjected to LLLT presented prolif-
eration rates similar to those of ZA-treated
cells, at both energy doses tested
(P > 0.05).
When the cultured cells were subjected
solely to LLLT, cell proliferation was
increased at both energy doses
(P < 0.05). The highest cell proliferation
rate was observed at 3 J/cm2 (Table 3).
Concerning cell apoptosis, both energy
doses used in this study resulted in similar
apoptosis rates when compared to the
control group (G1), in which the cells
received no treatment, and between them
(P > 0.05). The lowest apoptosis rate was
observed for the cells irradiated at 3 J/cm2
(Table 4 and Fig. 1).
Significantly increased apoptosis
occurred for ZA-treated cells compared
with the control group (P < 0.05). How-
ever, no difference was detected when
ZA-treated cells were subjected to laser
irradiation (P > 0.05).
Discussion
Low-level laser irradiation has been used as
an adjuvant therapy for bisphosphonate-
induced osteonecrosis, mainly due to its
positive effects against pain, its capacity
to reduce oedema formation, and a notable
stimulation of tissue healing.9–12
The present study demonstrated that ZA
significantly decreased the proliferation of
cultured gingival fibroblasts and increased
cell apoptosis. Similar data have been
reported in previous studies,8,19,21 in
which the authors have stated that the
decreased proliferation of epithelial cells
and fibroblasts may interfere with the
repair of oral mucosal tissue. In addition,
in the present study it was shown that ZA
increased fibroblast apoptosis rates, as has
been reported previously.6,7,22
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Table 3. Proliferation rates (%) according to ZA treatment and LLLT.
Cell proliferation rate for
each experimental group,
median (IQR)*
Experimental groups (adjusted P-values of group comparisons)
Negative control
group
Positive control
group ZA 5 mM 0.5 J/cm2 ZA + 0.5 J/cm2 3 J/cm2 ZA + 3 J/cm2
Negative control group
(DMEM without FBS)
9.52 (0.00–19.04)
– P = 0.0001 P = 0.651 P = 0.003 P = 1.000 P = 0.0001 P = 0.651
Positive control group
(DMEM + 10% FBS) (G1)
104.76 (80.95–114.28)
– – P = 0.007 P = 1.000 P = 0.001 P = 0.005 P = 0.0001
ZA 5 mM (G2)
47.62 (23.80–57.14)
– – – P = 1.000 P = 1.000 P = 0.310 P = 1.000
0.5 J/cm2 (G3)
57.14 (57.14–71.43)
– – – – P = 0.761 P = 1.000 P = 0.005
ZA + 0.5 J/cm2 (G4)
38.09 (23.80–52.38)
– – – – – P = 0.077 P = 1.000
3 J/cm2 (G5)
76.19 (61.90–76.19)
– – – – – – P = 0.001
ZA + 3 J/cm2 (G6)
40.48 (38.09–53.57)
– – – – – – –
ZA, zoledronic acid; LLLT, low-level laser therapy; IQR, interquartile range; DMEM, Dulbecco’s modified Eagle’s medium; FBS, foetal bovine
serum.
* n = 8; Mann–Whitney, P > 0.05.
Table 4. Apoptosis rates of cultured gingival fibroblasts after ZA treatment and LLLT.
Cell apoptosis rate for each
experimental group, median
(IQR)*
Experimental groups (adjusted P-values of group comparisons)
Positive control
group
Negative control
group ZA 5 mM 0.5 J/cm2 ZA + 0.5 J/cm2 3 J/cm2 ZA + 3 J/cm2
Positive control group
(DNase)
102.5 (90.5–106.9)
– P = 0.0001 P = 1.000 P = 0.001 P = 0.615 P = 0.274 P = 0.0001
Negative control group (G1)
2.1 (1.6–2.7)
– – P = 0.0001 P = 1.000 P = 0.0001 P = 1.000 P = 0.0001
ZA 5 mM (G2)
27.7 (20.9–33.4)
– – – P = 0.015 P = 1.000 P = 0.005 P = 1.000
0.5 J/cm2 (G3)
2.2 (1.2–2.3)
– – – – P = 0.0001 P = 1.000 P = 0.159
ZA + 0.5 J/cm2 (G4)
22.7 (16.0–29.5)
– – – – – P = 0.055 P = 1.000
3 J/cm2 (G5)
1.6 (1.07–2.3)
– – – – – – P = 0.061
ZA + 3 J/cm2 (G6)
21.9 (19.4–24.7)
– – – – – – –
ZA, zoledronic acid; LLLT, low-level laser therapy; IQR, interquartile range.
ZA acts on the farnesyl diphosphate
synthase signalling pathway, decreasing
geranylgeraniol production, which is
necessary in the location of intracellular
proteins that play important roles in dif-
ferent cell functions.4,23 Recent studies
have demonstrated that the decrease in
geranylgeraniol production by ZA-treated
cells significantly reduces cell prolifera-
tion and migration, as well as inducing cell
apoptosis.23,24 Conversely, increased cell
proliferation rates have been observed for
LLLT-treated cells at both energy doses
selected for use in this study (0.5 and
3 J/cm2), confirming that this type of
therapy, at specific parameter levels,
may biomodulate cell functions.13–
18,25,26 Most of the effects of LLLT have
been associated with the activation of
mitochondrial cytochrome c oxidase,
which leads to increased adenosine tripho-
sphate (ATP) production and the activation
of several cell-signalling pathways.27,28 In
the present study, it may be speculated that
similar laser biostimulation occurred in
those irradiated fibroblasts that presented
significantly increased proliferation
(Table 3).
When ZA-treated cells were subjected
to LLLT, no increased cell proliferation
was detected, suggesting that the concen-
tration of ZA used in the present study
was capable of causing immediate and
intense cell damage. Therefore, one may
speculate that the irreversible cell damage
caused by ZA on the cultured fibroblasts
may interfere negatively with tissue repair
processes in vivo, as described in previous
studies.1,29 It appears that the intense toxic
effect caused by ZA induced rapid fibro-
blast apoptosis, such that subsequent laser
irradiation of ZA-treated cells at specific
parameter levels had no positive effects,
since the apoptotic process is considered
an irreversible pathway.30
In this study, we demonstrated that
LLLT can biostimulate cultured gingival
fibroblasts, leading to increased cell pro-
liferation. Analysis of these data may
explain, at least in part, the excellent
clinical results of this therapy.9–12 Addi-
tionally, LLLT may be effective in bio-
modulating the oral mucosal cells adjacent
to the necrotic area, thus improving the
local tissue-healing process. However,
further in vitro and in vivo studies are
needed to elucidate the effects of bispho-
sphonates on oral mucosal cells and the
association of these drugs with LLLT,
which will certainly favour its use in the
treatment of osteonecrosis.
According to the methodology used in
the present study and based on analysis of
the data obtained, it can be concluded that
LLLT at selected parameter levels is cap-
able of increasing gingival fibroblast pro-
liferation, which is directly related to
tissue healing potential. However, this
therapy was not efficient in recovering
the activity of this type of cell previously
damaged by zoledronic acid.
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